CPHI & PMEC Shenzhen 2026
China is the world’s 2nd largest pharma market, which is valued at USD 282.07bn in 2024, and projected to reach USD 402bn by 2029.
AI in pharma is surging at 41.52% CAGR, the fastest across all sectors.
Why Shenzhen?
Shenzhen’s 1,300+ biotech companies generate USD 14bn annually, leading China’s cell and gene therapy sector. The Greater Bay Area targets USD 50bn in biomedical output via Shenzhen-Hong Kong collaboration.
Why attend?
Network and connect with 15,000+ pharma professionals at CPHI & PMEC Shenzhen, the launchpad for next-generation pharma.
Explore the latest innovations from 800+ exhibitors across the pharmaceutical supply chain, from R&D to manufacturing
Immerse yourself in rapid innovation, investigational drugs, cutting-edge biotech, CAR-T therapies, and advanced machinery, all under one roof.
Stay ahead with expert insights on emerging trends, cross-border opportunities, and next-generation technologies.
Dates: Sept. 16–18, 2026
Location: Shenzhen Convention & Exhibition Center (SZCEC), Shenzhen, China
